International Society for Stem Cell Application (ISSCA) Returns to Peru with World Conference on Regenerative Medicine and Cellular Therapies
Overview of the Conference
Miami, Florida – The International Society for Stem Cell Application (ISSCA), a distinguished division of the Global Stem Cells Group (GSCG), is excited to announce its highly anticipated international conference on Regenerative Medicine and Cellular Therapies. Scheduled to unfold in the dynamic city of Lima, Peru, this groundbreaking event will span two immersive days, from September 6th to 7th, 2024. Day one will be dedicated to enlightening conferences, while day two will offer hands-on sessions, providing attendees with a comprehensive learning experience.
Key Organizers and Participants
Renowned urologist Dr. Jorge Saldaña, certified by ISSCA and highly regarded in the region, will play a key role in organizing the conference. The event will also serve as the venue for Dr. Saldaña’s appointment as the director of the ISSCA chapter in Peru. This significant appointment is scheduled for September 6th, further underscoring his dedication to advancing regenerative medicine not only in Peru but also in neighboring regions of Latin America.
Objectives and Highlights
The conference aims to assemble leading scientists and medical professionals worldwide, offering a unique platform to explore and discuss the latest advancements in regenerative medicine. With an array of elite speakers, including distinguished scientists and physicians renowned for their contributions to the field, attendees can anticipate gaining profound insights into the cutting-edge clinical applications of stem cell therapies.
Innovations in Regenerative Medicine
Attendees are expected to be at the forefront of revolutionary technologies in regenerative medicine. From the latest breakthroughs reshaping healthcare to innovative tools enhancing clinical practice, participants will uncover advancements poised to elevate their practice and enhance patient care.
Comprehensive Learning Experience
This conference provides a holistic understanding of regenerative medicine, spanning foundational principles to cutting-edge applications. Attendees are anticipated to leave equipped with the essential knowledge to navigate the rapidly evolving landscape of regenerative medicine.
Hands-On Training Sessions
Beyond theoretical discourse, the conference offers invaluable hands-on training sessions led by ISSCA-certified instructors. Attendees will gain practical experience in both aesthetic and clinical applications of stem cell therapy, ensuring they leave equipped with skills ready for immediate implementation.
ISSCA’s Commitment to Peru
ISSCA is proud to bring its expertise back to Lima, Peru, reaffirming its presence in the southern cone with this global conference. Benito Novas, founder of Global Stem Cells Group and head of relationships of ISSCA, expresses his excitement, stating, “I’m thrilled to return to Peru with new technologies in the field of regenerative medicine. We will be providing local doctors and neighboring regions with the latest advancements in the field. Regenerative medicine is the future of healthcare as more research is conducted and products are developed to offer superior services.”
Expert Engagement and Practical Relevance
Benito adds, “The conference will feature world-renowned experts engaging directly with live trainees and patients to impart diverse cellular and procedural therapy techniques. These sessions will utilize locally available tools, ensuring practical applicability and relevance to the attendees’ contexts.”
ISSCA’s Global Recognition
As an acclaimed stakeholder in regenerative medicine and stem cell therapy, ISSCA offers a globally recognized certification to physicians and professionals, highlighting its fascinating track record in this highly sought-after field. According to Dr. Saldaña, “ISSCA has always been a pioneer in the world of regenerative medicine, serving as a worldwide reference. Having them here once again with their world conference is a fantastic opportunity, and I’m genuinely delighted to be part of this momentous event.”
Tailored for Local Trainees
The Conference considers the needs of local trainees using a thorough scheduling process. Initial consultations between the trainees and ISSCA will inform equipment and kits availability, materials, underlying costs, and any other needs to be met during the main event.
About ISSCA
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The mission of ISSCA is to establish itself as a global leader in regenerative medicine certification, education, research, and training. ISSCA provides certification training in cities worldwide because it recognizes the importance of standards and certifications in regenerative medicine as a medical specialty. To help more people, both locally and globally, as the demand for more doctors interested in and comfortable with regenerative medicine surges, ISSCA’s mission is to advance quality and uniformity in regenerative medicine worldwide.
About Global Stem Cells Group
The Global Stem Cell Group is a family of several companies focused on stem cell medicine and research. The company uses its network to bring leadership in regenerative medicine training, research, and patient applications. GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to patients worldwide. The company also partners with policymakers, educators, and regulators to promote regenerative medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331.
Safe Harbor Statement
Statements in this news release may be “forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
